why choose us

300×250 Ad Slot

Research Article: Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study

Date Published: 2023-07-06

Introduction:
Gynecological cancer, majorly comprised of cervical, endometrial, and ovarian cancer, is one of the leading causes of death among women. Despite the outcomes related to advanced gynecological cancer have been substantially improved in the past decades, resistance or nonresponse to standard treatment, in particular the first-line treatment, challenges the overall survival of patients with advanced gynecological cancer. Chemotherapy, immunotherapy, and targeted therapy have been recommended to treat advanced…

Read more

300×250 Ad Slot